高级检索
当前位置: 首页 > 详情页

Dosage dependence of the effect of Ginkgo biloba on the rat retinal ganglion cell survival after optic nerve crush

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Capital Univ Med Sci, Dept Ophthalmol, Beijing Inst Ophthalmol, Beijing Tongren Hosp, Beijing 100005, Peoples R China [2]Univ Heidelberg, Dept Ophthalmol, Fac Clin Med Mannheim, D-6800 Mannheim, Germany
出处:
ISSN:

关键词: neuroprotection optic nerve crush Ginkgo biloba flavenoids

摘要:
Purpose To investigate the dosage dependence of the Ginkgo biloba effect on retinal ganglion cell survival in the rat optic nerve crush model. Methods The study included 56 Sprague-Dawley rats, the right optic nerve of which was crushed in a standardized manner. Two hours after the crush and once daily during the follow-up, the animals received intragastral applications of saline (saline group; n=13), or of a G. biloba extract of 0.25% concentration (n=14; low-dosage group), 1% concentration (n=15; medium-dosage group), or 4% concentration (n=14; high-dosage group). At 23 days after the optic nerve crush, the retinal ganglion cells were retrogradely labelled by injecting 3% fluorogold into the superior colliculi of the brain. At 4 weeks after baseline, the animals were killed. Retinal flat mount photographs were assessed for number and density of the retinal ganglion cells. Results The mean survival rate defined as the ratio of retinal ganglion cell density in the right eye with optic nerve crash divided by the retinal ganglion cell density in left eye without optic nerve intervention increased significantly (P<0.001) from 58.4 +/- 9.0% in the saline group to 68.5 +/- 5.7% in the low-dosage group, to 73.7 +/- 6.4% in the medium-dosage group, and to 74.2 +/- 6.8% in the high-dosage group. Conclusions Intragastral applications of a G. biloba extract applied after an experimental and standardized optic nerve crush in rats were associated with a higher survival rate of retinal ganglion cells in a dosage-dependent manner. Eye (2009) 23, 1598-1604; doi:10.1038/eye.2008.286; published online 26 September 2008

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2008]版:
大类 | 3 区 医学
小类 | 3 区 眼科学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 眼科学
JCR分区:
出版当年[2007]版:
Q2 OPHTHALMOLOGY
最新[2023]版:
Q1 OPHTHALMOLOGY Q2 OPHTHALMOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2007版] 出版当年五年平均 出版前一年[2006版] 出版后一年[2008版]

第一作者:
第一作者机构: [1]Capital Univ Med Sci, Dept Ophthalmol, Beijing Inst Ophthalmol, Beijing Tongren Hosp, Beijing 100005, Peoples R China
通讯作者:
通讯机构: [1]Capital Univ Med Sci, Dept Ophthalmol, Beijing Inst Ophthalmol, Beijing Tongren Hosp, Beijing 100005, Peoples R China [2]Univ Heidelberg, Dept Ophthalmol, Fac Clin Med Mannheim, D-6800 Mannheim, Germany [*1]Capital Univ Med Sci, Dept Ophthalmol, Beijing Inst Ophthalmol, Beijing Tongren Hosp, 17 Hougou St, Beijing 100005, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21166 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)